Kcentra 1000 units 1S
Ended Awarded
- Contract number
- SPE2DR26FBTAD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,902
Award facts
- Contract value 100% obligated
- $12,901.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,901.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 1,000 units of Kcentra. The award, issued on October 29, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply pharmaceutical products to Department of Defense healthcare facilities worldwide. The IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036.
As an established critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated substantial contracting activity with DLA's Medical Supply Chain division, supplying an extensive portfolio including branded and generic medications, biologics, vaccines, and specialty pharmaceuticals. Kcentra, a prothrombin complex concentrate used for urgent reversal of warfarin anticoagulation, represents the type of specialty pharmaceutical product critical to military medical operations. The delivery order performance location is Park Ridge, Illinois, with an ultimate completion date of November 12, 2025. No subcontractors are identified in the award documentation, with DMS Pharmaceutical Group performing as the sole contractor.
Quick answers
Who was awarded contract SPE2DR26FBTAD?
SPE2DR26FBTAD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DR26FBTAD worth?
The government has obligated $12,902 on SPE2DR26FBTAD.
Is contract SPE2DR26FBTAD an order under another contract?
Yes. SPE2DR26FBTAD is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTAD competed?
The extent of competition for SPE2DR26FBTAD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award